* Active disease was de ned as spontaneous coughing on 2 or more consecutive days.
1
Scott-Garrard MM, Chiang YW, David F. Comparative onset of immunity of oral and
intranasal vaccines against challenge with Bordetella bronchiseptica. Vet Rec.
RECOMBITEK
®
is a registered trademark of
Boehringer Ingelheim Animal Health USA Inc.
©2019 Boehringer Ingelheim Animal Health USA Inc.,
Duluth, GA. All rights reserved. PET-0912-REC0119.
RAPID,
EFFECTIVE,
ORAL
BORDETELLA
PROTECTION
MEANS MEANS
PROVEN. PROVEN.
RECOMBITEK
®
RAPID,
EFFECTIVE,
ORAL
BORDETELLA
PROTECTION
MEANS
PROVEN.
* Active disease was de ned as spontaneous coughing on 2 or more consecutive days.
Scott-Garrard MM, Chiang YW, David F. Comparative onset of immunity of oral and
Bordetella bronchiseptica. Vet Rec
EFFECTIVE,
1
BORDETELLA
PROTECTION
THE ONLY oral Bordetella vaccine with published
data indicating protection against B. bronchiseptica
challenge 7 days after vaccination.
In a study, seven days after vaccination, all
dogs were challenged with two virulent strains
of B. bronchiseptica via aerosolisation
0/10 Dogs 0/10 Dogs 8/9 Dogs
Number
of
Dogs
With
Active
Disease*
10
9
8
7
6
5
4
3
2
1
RECOMBITEK®
Oral
Bordetella
Intranasal
Bordetella
vaccine
Placebo
# of Dogs
A Boehringer Ingelheim Vaccine
PetVaccinesClinic.com
